Lucas Maia
Biologist, PhD in Medical Sciences, and postdoctoral researcher in neuroscience/psychedelic research at UNICAMP/UFRN
Data updated
Research Footprint
Lucas Maia appears in 7 tracked papers (2020–2024), most studied alongside LSD, Ayahuasca and DMT, across Healthy Volunteers, Substance Use Disorders (SUD) and Anxiety Disorders.
Most-cited paper: LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking (41 citations).
Frequent co-authors: Luiz Tófoli, Draulio Araújo and Amanda Feilding.
Background & Research
Lucas Oliveira Maia is a Brazilian biologist with advanced training in psychopharmacology and mental health. He has worked with the ICARO/UNICAMP psychedelic research group and is described in UNICAMP materials as researching therapeutic uses of psychedelics for psychiatric disorders. His publications include studies on ayahuasca, low-dose LSD, inhaled DMT, and the spiritual effects of psychedelics.
Key Impact
He is a prominent Brazilian psychedelic researcher whose work spans ayahuasca, LSD, DMT, smoking cessation, creativity, cognition, and spiritual well-being.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Lucas Maia is associated with.